ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 99 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $79 | -37.3% | 100 | 0.0% | 0.00% | – |
Q2 2023 | $126 | +72.6% | 100 | 0.0% | 0.00% | – |
Q1 2023 | $73 | +37.7% | 100 | 0.0% | 0.00% | – |
Q4 2022 | $53 | – | 100 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
Q4 2021 | $0 | – | 100 | 0.0% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 100 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $1,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
QCM Cayman, Ltd. | 22,301 | $36,000 | 0.22% |
XTX Topco Ltd | 17,275 | $28,000 | 0.02% |
TWO SIGMA INVESTMENTS, LP | 2,371,193 | $3,794,000 | 0.01% |
TWO SIGMA ADVISERS, LP | 1,597,930 | $2,557,000 | 0.01% |
D. E. Shaw & Co., Inc. | 4,147,809 | $6,637,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 129,916 | $208,000 | 0.01% |
Graham Capital Management, L.P. | 73,105 | $116,000 | 0.01% |
Caption Management, LLC | 300,000 | $480,000 | 0.01% |
Engineers Gate Manager LP | 60,809 | $97,000 | 0.00% |
Castleview Partners, LLC | 800 | $500,000 | 0.00% |